Ikarovec scientific team presented three poster and one oral communication at the Denver Association for Research in Vision and Ophthalmology (ARVO) conference, between 1st and 4th May 2022. The team showcased the four lead programmes and highlighted significant progress towards identifying candidate gene constructs for diabetic macular oedema, wet-form, neovascular age-related macular degeneration, geographic atrophy and ocular hypertension. The company expects to complete pre-clinical proof-of-concept studies by 3Q 2022 for diabetic macular oedema and geographic atrophy.